Blood Testing in Brain Disorders: Innovation to Community Impact
Event Details
Blood-based biomarkers are emerging as transformative tools for the diagnosis, prognosis, and management of neurological disorders. The UBC Core Facility for Neurology Biomarker Innovation (CFNBI) is Canada’s most comprehensive site for neurology biomarker research, connecting world-class laboratory medicine infrastructure and expertise with academic, clinical, industry, community, and government partners to accelerate the development, validation, and implementation of blood-based biomarkers. Through its commitment to scientific excellence and collaborative research, CFNBI has established itself as a leader in neurology biomarker innovation, committed to serving all Canadians.
Building on the momentum generated by our 2026 meeting and recognizing both the opportunities and challenges associated with integrating neurological biomarkers into clinical care across Canada, we are expanding the conference to a national stage in 2027. The conference will be held in Ottawa, providing a unique platform to bring together federal policymakers, national health organizations, researchers, clinicians, industry partners, and patient advocacy groups. This next iteration will focus not only on the latest scientific advances in biomarker research, but also on the policy, regulatory, infrastructure, reimbursement, and implementation considerations required to translate these discoveries into routine clinical practice.
In 2027, we are featuring the TRANSCENDENT Concussion Research Program, led by local researcher Dr. Roger Zemek, Senior Scientist at the CHEO Research Institute and Professor at the University of Ottawa.
Dates: May 12-14, 2027
Location: Canada Science and Technology Museum (1867 St. Laurent Blvd, Ottawa, ON K1G 5A3)
Registration Fee: $55 (in-person) | Free (virtual)
Fee waivers are available, see below for more information
Quick Links
Registration
In-Person Registration: $55 | Register Here
We are committed to making the conference as accessible as possible. Fee waivers are available, and attendees requiring one are encouraged to apply. For more information, please contact cfnbi.research@ubc.ca.
Virtual Registration: Free | Register Here
Cancellations:
Cancellations received on or before May 1, 2027 will be subject to a $10 cancellation fee.
Cancellations received after May 1, 2027 are non-refundable.
We appreciate your understanding and look forward to seeing you in Ottawa in May for our road-show.
Program
More details coming soon. Subject to change.
May 12, 2027
Join us for two public-facing afternoon sessions. Refreshments & light snacks included
Networking reception to conclude the day (RSVP required in registration).
May 13, 2027
Scientific Symposium Featuring a Full Day of Programming (lunch included)
Trainee and Early Career Mentorship Breakfast led by Dr. Diane Bovenkamp, Vice President, Scientific Affairs, BrightFocus Foundation (RSVP required in registration).
May 14, 2027
Interactive Working Group on p-tau217 Clinical Adoption and Fee Reimbursement in Canada (Invite only at this time; email cfnbi.research@ubc.ca to request to participate)
Venue Map
Funders and Sponsors
CFNBI’s 2027 conference is partially funded through the support of a Brain Canada Platform Support Grant:
CFNBI’s 2027 annual conference also benefits from the generous financial support of sponsors who impose no conditions or requirements on the conference, namely:
Interesting in sponsoring? Please email cfnbi.research@ubc.ca